Mount Sinai Chelsea — New York, New York

Mount Sinai Chelsea is a clinical research site located in New York, New York, United States 10011.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Mount Sinai Chelsea has participated in 49 clinical trials with 43 currently active.

Therapeutic areas: Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), NRG Oncology, Janssen Research & Development, LLC.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mount Sinai Chelsea?

Mount Sinai Chelsea has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mount Sinai Chelsea conducted?

Mount Sinai Chelsea has 49 clinical trials on record, with 43 currently active. Their work covers Endometrial Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma.

Is Mount Sinai Chelsea accredited by Crixeo Health?

Yes — Mount Sinai Chelsea holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mount Sinai Chelsea?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.